Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
Amer H. Zureikat, Ibrahim Nassour, David L Bartlett, Annissa Desilva, Lance A. Liotta, Aatur D. Singhi, Virginia Espina, Alessandro Paniccia, Samer AlMasri, Nathan Bahary, Brian A. Boone, Herbert J. Zeh, Patricia Loughran, Michael T. Lotze, Mazen S. Zenati
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Introduction Preoperative autophagy inhibition with hydroxychloroquine (HCQ) in combination with gemcitabine in pancreatic adenocarcinoma (PDAC) has been shown to be safe and effective in inducing a serum biomarker response and increase resection rat
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Pranav Murthy, Amr I. Al Abbas, Mazen S. Zenati, Nathan Bahary, Michael T. Lotze, Amer H. Zureikat, Brian A. Boone, Caroline J. Rieser, Herbert J. Zeh
Publikováno v:
Ann Surg Oncol
BACKGROUND. The systemic immune-inflammation index (SII), calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival for patients with pancreatic ductal adenocarcinoma (PDAC) when assessed a
Autor:
Nathan Bahary, Ahmad Hamad, Herbert J. Zeh, Mazen S. Zenati, Amer H. Zureikat, Mashaal Dhir, Aatur D. Singhi, Melissa E. Hogg
Publikováno v:
Annals of surgical oncology. 25(7)
Both FOLFIRINOX and gemcitabine/nab-paclitaxel (G-nP) are used increasingly in the neoadjuvant treatment (NAT) of pancreatic ductal adenocarcinoma (PDA). This study aimed to compare neoadjuvant FOLFIRINOX and G-nP in the treatment of resectable (R) a
Autor:
Nathan Bahary, Jennifer Steve, Herbert J. Zeh, David L. Bartlett, Amer H. Zureikat, Brian A. Boone, Melissa E. Hogg, Mazen S. Zenati, Aatur D. Singhi
Publikováno v:
Annals of Surgical Oncology. 21:4351-4358
Baseline carbohydrate antigen 19-9 (CA 19-9) is a useful prognostic marker in pancreatic ductal adenocarcinoma (PDA); however, data on the significance of a change in CA 19-9 following neoadjuvant therapy are lacking.All patients receiving neoadjuvan
Autor:
Ahmad Hamad, Amer H. Zureikat, Nathan Bahary, Mazen S. Zenati, Jennifer Steve, Kenneth K. Lee, Irene Epelboym, Melissa E. Hogg, Herbert J. Zeh
Publikováno v:
Annals of surgical oncology. 24(9)
Receipt of 6 cycles of adjuvant chemotherapy (AC) is standard of care in pancreatic cancer (PC). Neoadjuvant chemotherapy (NAC) is increasingly utilized; however, optimal number of cycles needed alone or in combination with AC remains unknown. We sou
Autor:
Amer H. Zureikat, Lee M. Ocuin, Nathan Bahary, Sharon Winters, Jennifer Steve, Mazen S. Zenati, Filip Bednar, Melissa E. Hogg, Herbert J. Zeh
Publikováno v:
Annals of surgical oncology. 24(5)
Locally advanced unresectable pancreatic cancer (LAPC) historically portends a poor prognosis. FOLFIRINOX and gemcitabine/nab-paclitaxel have proven effective in the metastatic setting. We sought to evaluate the outcomes of these regimens compared wi
Autor:
Kenneth K.W. Lee, David L. Bartlett, James F. Pingpank, Amer H. Zureikat, Haroon A. Choudry, Matthew P. Holtzman, Mazen S. Zenati, Lekshmi Ramalingam, Heather Jones, Herbert J. Zeh, Joshua Winer, Steven A. Ahrendt
Publikováno v:
Annals of Surgical Oncology. 21:1456-1462
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal carcinomatosis (PC) of colorectal origin increases survival (OS) compared to systemic chemotherapy alone. Signet ring histology demonstrates aggressive
Autor:
Haroon A. Choudry, Matthew P. Holtzman, Steven A. Ahrendt, David L. Bartlett, Heather Jones, Herbert J. Zeh, Joshua Winer, Arun Mavanur, Deepa Magge, Amer H. Zureikat, Kenneth K.W. Lee, Mazen S. Zenati, Lekshmi Ramalingam, James F. Pingpank
Publikováno v:
Annals of Surgical Oncology. 21:1448-1455
Background. Peritoneal carcinomatosis from gastric cancer (GPC) responds poorly to systemic chemotherapy. Limited published data demonstrate improved outcomes after aggressive locoregional therapies. We assessed the efficacy of cytoreductive surgery
Autor:
Herbert J. Zeh, Mazen S. Zenati, Nathan Bahary, Matthew J. Weiss, Jennifer Steve, G. Paul Wright, Amer H. Zuriekat, Katherine E. Poruk, Melissa E. Hogg, Christopher L. Wolfgang
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 20(11)
Patients with metastatic pancreatic adenocarcinoma have traditionally been offered palliative chemotherapy alone, and the role of surgery in these patients remains unknown. A bi-institutional retrospective review was performed for patients with metas